We are #2 because we put KIDS FIRST
Partnering Opportunities
Featured Innovations
Use of CXCR3 Inhibitors for Reducing and Preventing Preterm Birth and Pregnancy Complications
This technology utilizes methods and compositions related to reducing the risk of or preventing fetal wastage by administering CXCR3 inhibitors.
Therapy for Treatment of Myelodysplastic Syndrome (MDS)
IRAK1 is a drugable target for treatment of MDS, and IRAK1/BCL2 inhibitors synergistically co-treat MDS.
A Growing Pipeline of Innovations
Find out how we are building the research-to-market bridge in the latest Research Horizons
Partner with Us
View our innovation portfolio
Contact Us
innovation.ventures@cchmc.org
New Funding Opportunity
A New Funding Opportunity & Research Collaboration with BridgeBio Pharma